All Research on Pharmaceutical Manufacturers in Europe

Insight

Case Studies
Case Studies

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

This case study looks at Teva's operations and the market in which it operates, Copaxone, Teva's best-selling drug, and M&A activity Teva has been involved in over recent years, and whether or not it has been successful.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Orphan Drugs: Rescue from the patent cliff

Big Pharma has gone through some significant changes in recent years: many “blockbuster” drugs are losing their patents. In the orphan drugs market, where companies can charge high premiums for drugs which have little to no competition.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Pfizer Inc: Re-entry to the OTC healthcare market

Pfizer exited the OTC healthcare market in 2006 with the sale of its Consumer Healthcare division. In 2009, Pfizer re-entered the market. This case study will examine Pfizer's growth, disposal of the OTC division, and the subsequent market re-entry.

Published By MarketLine
$495
Buy

View all Insight >>

Market Data

Databook
Databook

Company Financials: Shire plc

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
$75
Buy

Profiles

Company Profile
Company Profile

Merck KGaA

Merck KGaA (or 'the group') is a leading company for high-tech products in the pharmaceutical and chemical sectors. The Merck family holds an approximately 70% interest in the group. Merck KGaA operates in 66 countries across the world. It is headquartered in Darmstadt, Germany, and employed 38,154 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

AstraZeneca PLC

AstraZeneca (or 'the company'), a UK-based global biopharmaceutical company, is engaged in developing, manufacturing and marketing prescription pharmaceuticals in several therapeutic areas. The company operates primarily in the Americas, Europe and Asia. It is headquartered in London, the UK, and employed about 51,500 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Actelion Ltd

Actelion (or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic small-molecule drugs to address high unmet medical needs. It has affiliates in more than 30 countries including the US, Canada, Brazil, Australia, Japan and Switzerland, which provide distribution, sales and marketing services. Actelion has operations in the Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employed 2,422 people as

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.